Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
ETFs with NVS as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.83%||Market Vectors Pharmaceutical ETF (PPH)||-8.79 (-12.20%)|
|7.89%||BLDRS Europe 100 ADR Index Fund (ADRU)||-3.69 (-15.30%)|
|6.38%||BLDRS Developed Markets 100 ADR Index Fund (ADRD)||-3.88 (-15.78%)|
|2.03%||First Trust RBA Quality Income ETF (QINC)||-1.98 (-9.02%)|
|1.49%||PowerShares Intl Dividend Achievers (PID)||-4.01 (-21.70%)|
Company Description (as filed with the SEC)
Novartis AG was incorporated on February 29, 1996 under the laws of Switzerland as a stock corporation (Aktiengesellschaft) with an indefinite duration. On December 20, 1996, our predecessor companies, Ciba-Geigy AG and Sandoz AG, merged into this new entity, creating Novartis. We are domiciled in and governed by the laws of Switzerland. Our registered office is located at the following address: Novartis AG Lichtstrasse 35 CH-4056 Basel, Switzerland Telephone: 011-41-61-324-1111 Web: www.novartis.com Novartis is a multinational group of companies specializing in the research, development, manufacturing and marketing of a broad range of healthcare products led by innovative pharmaceuticals. Novartis AG, our Swiss holding company, owns, directly or indirectly, all of our significant operating companies. For a list of our significant operating subsidiaries, see "Item 18. Financial Statements--Note 32. ... More ...
Where does NVS fit in the risk graph?
|Annual EPS Est:||$5.23|
|Quarterly EPS Est:||1.33|